Charles Kennergren

TL;DR: Cleveland Clinic, Department of Cardiovascular Medicine, Cleveland, OH, Ohio State University, Division of ardiovascular Medicine, Columbus, Ohio, Broward General Medical Center, Fort Lauderdale, FL, University Hospital, ivision of cardiovascular medicine, Pisa, Italy, University of Miami, Cardiothoracic Surgery, Miami, FL as discussed by the authors, St. Thomas esearch Institute and Providence St. Joseph Medical enter, Burbank, CA, American Heart Association Representative.

TL;DR: Fred M. Kusumoto,MD, FHRS, FACC, Chair, Mark H. Schoenfeld, MD, F hrs, F ACC, FAHA, CCDS, Vice-Chair, Bruce L. Wilkoff, MD; Ulrika M. Birgersdotter-Green, MD.

TL;DR: Studies have demonstrated equivalent defibrillation efficacy and all-cause mortality in patients with single and dual coil implantable cardioverter-defibrillator (ICD) leads, but the vast majority of implanted ICD leads are dual coil.

TL;DR: The ELECTRa study is the largest prospective registry on TLE and confirmed the safety and efficacy of the current practice of TLE, with a higher success rate with lower all cause complication and mortality rates in high volume compared with low volume centres.

TL;DR: Adjunctive use of an antibacterial envelope resulted in a significantly lower incidence of major CIED infections than standard‐of‐care infection‐prevention strategies alone, without a higher incidence of complications.